Labroots is pleased to announce the 3rd annual event in the Immuno-Oncology Virtual Event Series taking place on May 1, 2024. Immuno-Oncology is at the forefront of groundbreaking research in cancer therapeutics, widely hailed as one of the most promising frontiers in the battle against cancer. This cutting-edge field delves into the intricate interplay between the immune system and cancer cells to harness the body's natural defenses to combat cancer.

How our immune system can be mobilized to recognize and target cancerous cells is the focus of immuno-oncology. By understanding the body's immune response, immunotherapies can empower the immune system to identify and eliminate tumors with remarkable precision, offering new hope to patients facing various types of cancer.

Exploring the intricacies of immuno-oncology, the speakers and tracks in this virtual event series elucidate the remarkable strategies and therapies that promise to reshape the cancer treatment landscape. 

Last year's event included the following tracks and topics:

New Advancements in Immuno-Oncology

• Cell Therapy Innovation

• Checkpoint Inhibitors

• Innate Immunity Considerations

• Microbiome and Cancer

• New Adaptive Immunity Considerations

• Neoantigen Vaccines

• Exosomes in Cancer Detection

Emerging Targets for Immuno-Oncology Therapy

• Overcoming Obstacles in the Immunosuppressive Tumor Micro-environment

• Molecular and Epigenetic Modulation

• Cancer Immunotherapeutics and COVID-19

• Novel Cell Therapy Targets and Engineering Strategies

Advancing Cancer Immunotherapies to the Clinic

• Translational

In the dynamic landscape of immuno-oncology, various immunotherapies take center stage. These therapies exhibit the potential to function independently, collaboratively, or synergistically with other treatments, presenting a multifaceted approach to the formidable challenge of eradicating cancer.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2024 Immuno-Oncology Virtual Event Series. Submission is free. Submit your abstract here.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global cell biology community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.

Connect With Us!

When you attend the event remember to use the hashtag #LRimmuno to follow the conversation and connect with other members of the global Immunology and Oncology community!

Follow @Immunology_LR on Twitter and Labroots Immunology on Facebook to connect with our specialist Immunology Writers and stay up to date with the latest Trending News in Immunology! 

Now, you can also join our professional community on LinkedIn! Check out the Microbiology and Immunology networking group on LinkedIn to meet others in your field and grow your network!